Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Hain Celestial posts mixed Q3 results, lowers full-year guidance

EditorRachael Rajan
Published 08/05/2024, 13:24
HAIN
-

HOBOKEN, N.J. - Hain Celestial Group (NASDAQ:HAIN), a company specializing in health and wellness products, reported its fiscal third-quarter results with mixed outcomes. Shares were trading down 0.75% in Wednesday's premarket session.

The company's earnings per share (EPS) for the quarter were $0.13, surpassing analyst expectations by $0.05. However, revenue fell short, coming in at $438.4 million against the consensus estimate of $465.77 million.

In comparison to the same quarter last year, Hain Celestial's net sales experienced a decline of 3.7%, with both organic net sales and overall net sales reflecting this decrease. Despite the drop in net sales, the company saw improvements in profitability metrics, with a 60-basis point increase in gross profit margin and a significant reduction in net loss from the previous year.

The company's CEO, Wendy Davidson, acknowledged the challenges faced, particularly in the North American segment, which saw a 6.5% decrease in net sales, primarily due to lower sales in personal care and baby and kids categories. In contrast, the International segment reported a modest 1.0% year-over-year growth in net sales.

Looking ahead, Hain Celestial has revised its full-year guidance for fiscal 2024, citing slower-than-expected recovery in its infant formula business, underperformance in the Snacks category, and delays in stabilizing the Personal Care business. Organic net sales are anticipated to decline between 3 to 4%, with adjusted EBITDA expected to range from $150 million to $155 million. The company has reaffirmed its free cash flow guidance of $40 million to $45 million.

The company's CFO, Lee Boyce, expressed determination to address the issues, stating, "We are aggressively addressing Personal Care stabilization through portfolio and operating footprint consolidation, we are working closely with our formula supplier to ensure a full recovery beginning in the second half of 2024, and we have realigned the commercial business in North America with a series of leadership changes and a clear plan to accelerate our execution in the region."

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.